Sabine Buxbaum

The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates

Lorenza Scarpa, Sabine Buxbaum, Dorota Kendler et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 113 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme

Eva‐Maria Gamper, Lisa M. Wintner, Margarida Rodrigues et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 98 citations · Full text

Medicine, Endocrinology, Nuclear Medicine +16

Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle

Bernhard Nilica, Dietmar Waitz, Vlado Stevanovic et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 93 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

Johanna Maffey-Steffan, Lorenza Scarpa, Anna Svirydenka et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 56 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy

Christian Uprimny, Anna Svirydenka, Josef Fritz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 49 citations

Medicine, Nuclear Medicine, Radiology +14